Home
Shilpa Medicare Ltd Board of Directors
Board of Directors at Shilpa Medicare Ltd
Independent Director
Independent Director
Independent Director
Independent Director
Chairman (Non-Executive)
Key Highlights
- Omprakash Inani continues to serve as the Chairman (Non-Executive) in 2024, maintaining the same position as in the previous year.
- Vishnukant Bhutada continues to serve as the Managing Director in 2024, maintaining the same position as in the previous year.
- Sharath Reddy Kalakota continues to serve as the Whole-time Director in 2024, maintaining the same position as in the previous year.
- Arvind Vasudeva continues to serve as the Independent Director in 2024, maintaining the same position as in the previous year.
- Hetal Gandhi continues to serve as the Independent Director in 2024, maintaining the same position as in the previous year.

Shilpa Medicare Ltd
NSE: SHILPAMED
Share Price
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 675.5 |
20 Feb 2025 | 682.4 |
19 Feb 2025 | 657.25 |
18 Feb 2025 | 637.85 |
17 Feb 2025 | 662.25 |
14 Feb 2025 | 647.9 |
13 Feb 2025 | 679.95 |
12 Feb 2025 | 661.2 |
11 Feb 2025 | 663.55 |
10 Feb 2025 | 689.4 |
Company Fundamentals for Shilpa Medicare Ltd
Market Cap
6,605 Cr
EPS
8.7
P/E Ratio (TTM)
78.0
P/B Ratio (TTM)
2.8
Day’s High
689.8
Day’s Low
671.55
DTE
0.2
ROE
2.6
52 Week High
959.95
52 Week Low
384.8
ROCE
7.3
Market Price of Shilpa Medicare Ltd
1M
1Y
3Y
5Y
Shilpa Medicare Ltd News Hub
Shilpa Medicare to conduct AGM
Shilpa Medicare announced that the 37th Annual General Meeting (AGM) of the company will be held on
Read more
16 Aug 24
Shilpa Medicare consolidated net profit rises 1091.53% in the June 2024 quarter
Net profit of Shilpa Medicare rose 1091.53% to Rs 14.06 crore in the quarter ended June 2024 as agai
Read more
08 Aug 24
Shilpa Medicare to announce Quarterly Result
Shilpa Medicare will hold a meeting of the Board of Directors of the Company on 8 August 2024. Power
Read more
02 Aug 24
Shilpa Medicare update on its CDMO customer - Unicycive Therapeutics
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) announced the submission of NDA to U.S. FDA for Oxylanth
Read more
04 Sept 24